LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 2 | B21 | 72 | hr | 1694 | 11478 | 11309 | 1.0149 | 1.0108 |
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 3 | B21 | 72 | hr | 1694 | 11940 | 11121 | 1.0736 | 1.0530 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 1694 | 11355 | 11220 | 1.0119 | 1.0087 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 1694 | 11357 | 11309 | 1.0042 | 1.0031 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 1694 | 11801 | 11121 | 1.0611 | 1.0442 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 1694 | 3906 | 11220 | 0.3481 | 0.3583 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1694 | 3890 | 11309 | 0.3440 | 0.3546 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1694 | 4014 | 11121 | 0.3609 | 0.3740 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1694 | 5634 | 11220 | 0.5021 | 0.5536 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1694 | 6560 | 11309 | 0.5801 | 0.6393 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1694 | 6416 | 11121 | 0.5769 | 0.6332 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1694 | 8649 | 11042 | 0.7833 | 0.8273 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1694 | 9834 | 11099 | 0.8860 | 0.9127 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1694 | 8456 | 11168 | 0.7571 | 0.8056 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1694 | 3817 | 11220 | 0.3402 | 0.3469 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1694 | 3567 | 11309 | 0.3154 | 0.3124 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1694 | 3743 | 11121 | 0.3366 | 0.3391 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1694 | 6295 | 11042 | 0.5701 | 0.6247 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1694 | 6120 | 11099 | 0.5514 | 0.6058 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1694 | 5629 | 11168 | 0.5040 | 0.5548 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1694 | 2615 | 11220 | 0.2331 | 0.1725 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1694 | 2580 | 11309 | 0.2281 | 0.1660 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1694 | 2789 | 11121 | 0.2508 | 0.2016 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1694 | 3146 | 11042 | 0.2849 | 0.2572 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1694 | 2954 | 11099 | 0.2661 | 0.2275 |